Computational analysis to predict role of human microRNAs in Ebola virusgenome
Abstract
The Ebola virus is one of the most dangerous viruses in Filoviridae family. It causes fatal hemorrhagic fever in both non-human and human primates. The fatality rate is up to ninety percent. There is no effective treatment against EBOV infection so far. By using host microRNAs, we have explored for potential anti-viral therapeutics against EBOV infection, which may down-regulate viral gene expression in order to suppress viral replication. We have identified eight human miRNAs from eight potential hairpin sequences of EBOV genome. Our study provided an interesting hypothesis that those miRNAs are hsa-miR-3915, hsa-miR-6750-5p, hsa-miR-4452, hsa-miR-4796-5p, hsa-miR-671-3p, hsa-miR-5096, hsa-miR302c-3p and hsa-miR-2054. We suggested that these hairpin sequences could be use as anti-viral therapeutics to quell the replication of EBOV infection in human.
Keywords
Download Options
Introduction
The Ebola virus (EBOV)is already listed as a top categories pathogen by several organizations including WHO, CDC and NIH because fatality rate is up to ninety percent [4,7]. It is a member of Filoviridae family that causes fatal hemorrhagic fever including both human and non-human primates [1-3]. Several reports suggested that susceptible hosts can be died by most virulent species within ten days after the appearance of symptoms [4-5]. The first case of Ebola virus was reported in 1976 on the Africa region [6]. Five (5) different species of Ebola viruses have been reported so far. Among these except Reston, REBOV, all 4 are being capable of causing diseases in human [8-9]. As Ebola virus is enveloped, non-segmented, negative-strand RNA viruses and genome size approximately 19 kb in length, it has high fatality rate and easily transmissible [10-11]. The viral genome encodes seven structural proteins and one non-structural protein while viral proteins perform different functions including viral replication [11].
The miRNAs are small non-coding RNA molecule, genomically encoded, usually around twenty-two base pair in length and regulate genes expression at the post-transcriptional level either mRNA degradation or repress translation [12-14]. It is well documented that miRNAs operate their different biological or physiological functions including apoptosis, development, tumorigenesis, stress response, proliferation and fat metabolism [15-16]. Although, current monoclonal antibody (mAb) based therapies are thought to the most efficient against lethal Ebola virus infection in non-human primates. In this research study, we have proposed miRNA-based gene silencing activity as a suitable alternative, in addition to current vaccine mediate treatment.
Viral miRNAs are unique because it regulates both their own gene expression and host gene expression [18]. MiRNA genes are firstly transcribed into primary miRNA. Then they are cleaved by enzymatic activity of the RNase III ribonuclease Drosha into 60-90 base pair long hairpin intermediate known as pre-miRNA [18-20]. By the action of enzyme exportin-5 and ran pre-miRNAs are exported from nucleus to cytoplasm [19]. The pre-miRNAs are further cleaved by Drosha (another RNase III ribonuclease) in the cytoplasm and are formed into a double stranded RNA known as duplex mature RNA [19].RNA-induced silencing complex (RISC) that is one strand (guided strand) of duplex RNA, targets messenger RNA to degrade or repress translational activity [18].
Conclusion
The candidate potential miRNA targeting EBOV can be predicted by utilizing a series of bioinformatics tools that we have provided in this study. Our computational analysis suggested that miRNAs hsa-miR-3915, hsa-miR-6750-5p, hsa-miR-4452, hsa-miR-4796-5p, hsa-miR-671-3p, hsa-miR-5096, hsa-miR-302c-3p and hsa-miR-2054 can be utilized as some anti-viral therapeutics against EBOV infection in human. Some future studies related this in silico study is also suggested. In order to find out the efficacy of the miRNA against EBOV infection, in vitro studies need to be carried on. To find out the inhibition influence on viral replication by the selected human miRNA, further study should be designed targeting isolation and application of miRNA for the purpose.